Autonomix Medical, Inc. (AMIX) vs Lakewood-Amedex Biotherapeutics, Inc. (LABT)

A side-by-side comparison of Autonomix Medical, Inc. and Lakewood-Amedex Biotherapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Autonomix Medical, Inc. logo
AMIX
Autonomix Medical, Inc.
$2M
$3.55HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Lakewood-Amedex Biotherapeutics, Inc. logo
LABT
Lakewood-Amedex Biotherapeutics, Inc.
$1M
$0.84HealthcareDelayed quote: Oct 6, 2026, 9:58 AM EDT

Total return — AMIX vs LABT

growth of $100 · dividends reinvested · last 1y
AMIX -54.1% (-54.1%/yr)LABT -99.0% (-99.0%/yr)AMIX compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100$46$1
AMIX LABT

AMIX vs LABT: by the numbers

  • •AMIX is the larger company ($2M vs $1M market cap).

Metrics side by side

Valuation

MetricAMIXLABT
P/B ratio0.610.34

Profitability

MetricAMIXLABT
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-509.36%-169.64%
ROIC-518.15%-163.98%

Go deeper

Full AMIX analysisFull LABT analysisInteractive comparison tool

Dig into the metrics

Autonomix Medical ROELakewood-Amedex Biotherapeutics ROEAutonomix Medical operating marginLakewood-Amedex Biotherapeutics operating marginAutonomix Medical revenue growthLakewood-Amedex Biotherapeutics revenue growthAutonomix Medical free cash flowLakewood-Amedex Biotherapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.